SIROLLI, Vittorio
 Distribuzione geografica
Continente #
NA - Nord America 3.326
EU - Europa 2.824
AS - Asia 2.155
SA - Sud America 190
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 8
Totale 8.539
Nazione #
US - Stati Uniti d'America 3.275
CN - Cina 783
SG - Singapore 733
IT - Italia 531
IE - Irlanda 482
UA - Ucraina 452
SE - Svezia 357
TR - Turchia 326
GB - Regno Unito 259
DE - Germania 240
FR - Francia 209
IN - India 179
BR - Brasile 170
FI - Finlandia 107
RU - Federazione Russa 81
VN - Vietnam 41
CA - Canada 38
HK - Hong Kong 30
CZ - Repubblica Ceca 19
BE - Belgio 18
NL - Olanda 18
PL - Polonia 13
AT - Austria 12
BD - Bangladesh 12
IR - Iran 11
JP - Giappone 11
ZA - Sudafrica 8
AU - Australia 7
EG - Egitto 7
ES - Italia 7
MX - Messico 7
EU - Europa 6
DZ - Algeria 5
UZ - Uzbekistan 5
EC - Ecuador 4
IL - Israele 4
PY - Paraguay 4
VE - Venezuela 4
AR - Argentina 3
EE - Estonia 3
JO - Giordania 3
LT - Lituania 3
TW - Taiwan 3
AL - Albania 2
BB - Barbados 2
DK - Danimarca 2
KR - Corea 2
PA - Panama 2
PK - Pakistan 2
SA - Arabia Saudita 2
TN - Tunisia 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BJ - Benin 1
BO - Bolivia 1
BS - Bahamas 1
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
CY - Cipro 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
LV - Lettonia 1
LY - Libia 1
MA - Marocco 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SM - San Marino 1
SN - Senegal 1
SO - Somalia 1
Totale 8.539
Città #
Chandler 522
Jacksonville 514
Singapore 482
Dublin 480
Houston 307
Princeton 209
Southend 206
Beijing 182
Izmir 160
Ashburn 152
Nanjing 142
Chieti 137
Dearborn 125
Wilmington 82
Cambridge 81
Ann Arbor 77
Nanchang 75
The Dalles 65
Altamura 64
Santa Clara 62
Tongling 60
Los Angeles 54
New York 46
Boardman 42
Munich 41
Woodbridge 35
Hebei 32
Shenyang 32
Dong Ket 30
Hong Kong 29
Washington 29
Kunming 25
Tianjin 24
Pescara 23
Jiaxing 21
Milan 20
Brussels 18
Helsinki 18
Nuremberg 18
Brno 17
Hefei 17
Jinan 17
Kocaeli 17
Ottawa 17
São Paulo 17
Changsha 16
Rome 16
Düsseldorf 15
Hangzhou 13
Norwalk 13
San Mateo 12
Augusta 11
Brooklyn 11
Leawood 11
Shanghai 11
Zhengzhou 11
Ardabil 10
Bari 10
Ningbo 10
Stockholm 10
Tokyo 9
Warsaw 9
Boston 8
Catania 8
Guangzhou 8
Paris 8
San Francisco 8
Seattle 8
Atlanta 7
Cairo 7
Chicago 7
Frankfurt am Main 7
Lanzhou 7
Turku 7
Vienna 7
Amsterdam 6
Bologna 6
Canberra 6
Chennai 6
Council Bluffs 6
Falls Church 6
Grevenbroich 6
Lappeenranta 6
Naples 6
Belo Horizonte 5
Carmiano 5
Denver 5
Hanoi 5
London 5
Montreal 5
Orange 5
Porto Alegre 5
Rio de Janeiro 5
Romola 5
Vittuone 5
Algiers 4
Charlotte 4
Dallas 4
Johannesburg 4
Muzzana del Turgnano 4
Totale 5.247
Nome #
[Erythrocyte abnormalities and their possible role in cardiovascular complications of uremia] 409
Quali soluzioni future per la dialisi peritoneale? 171
Adherence of Uremic Erythrocytes to Vascular Endothelium decreases Endothelial Nitric Oxide Synthase Expression 148
Plasma protein carbonylation in chronic uremia 139
Cell activation and cellular-cellular interactions during hemodialysis: effect of dialyzer membrane 132
Adsorption and carbonylation of plasma proteins by dialyser membrane material: in vitro and in vivo proteomics investigations 128
Angiodysplasia of the small bowel: a possible cause of anemia even in mild chronic renal failure 126
Effect of peritoneal dialysis fluid containing osmo-metabolic agents on human endothelial cells 126
Calcium Sensing Receptor Expression in Ovine Amniotic Fluid Mesenchymal Stem Cells and the Potential Role of R-568 during Osteogenic Differentiation 126
Proteomic investigations on the effect of different membrane materials on blood protein adsorption during haemodialysis 125
Mechanisms of uremic erytrocyte-induced adhesion of human monocytes to cultured endothelial cells 124
Platelet-leukocyte interactions in hemodialysis patients: culprit or bystander? 121
Nephrotoxicity induced by chemotherapy [Nefrotossicita' da chemioterapici] 121
Proteomic analysis of protein adsorption capacity of different haemodialysis membranes 119
Beta2-microglobulin causes abnormal phosphatidylserine exposure in human red blood cells. 117
Proteomics characterization of protein adsorption onto hemodialysis membranes 114
Biocompatibility and functional performance of a polyethylene glycol acid-grafted cellulosic membrane for hemodialysis 112
Effect of erythropoietin on primed leucocyte expression profile. 111
L-carnitine inhibits a subset of platelet activation responses in chronic uraemia 111
Calcium Sensing Receptor activation by calcimimetic R-568 in human amniotic fluid mesenchymal stem cells: Correlation with osteogenic differentiation. 109
Calcimimetic R-568 and its enantiomer s-568 increase nitric oxide release in human endothelial cells 108
Update sull'impiego della proteomica in emodialisi 108
On-line HFR and removal of uremic toxins inducing the loss of phospholipidic asymmetry of the erythrocyte membrane [HFR on-line e rimozione di tossine uremiche inducenti la perdita dell'asimmetria fosfolipidica della membrana eritrocitaria.] 105
Platelet activation markers in patients with nephrotic syndrome: A comparative study of different platelet function tests 104
In vitro microbiology studies on a new peritoneal dialysis connector 104
Proteomic Investigations into Hemodialysis Therapy 104
Blood cell proteomics in chronic kidney disease 103
Examining hemodialyzer membrane performance using proteomic technologies 102
Uremic toxicity and anemia 101
Biocompatibility of DIAPES 100
Use of oral hypoglycemic agents in patients with chronic kidney failure 98
Nitric oxide synthetic pathway and cGMP levels are altered in red blood cells from end-stage renal disease patients 98
null 96
Urinary Peptidomic Biomarkers in Kidney Diseases 96
Wireless capsule endoscopy in the diagnostic of small intestine angiodysplasia in chronic uremic patient 95
Recovery time after hemodialysis is inversely associated with the ultrafiltration rate. 95
Removal of uremic plasma factors using different dialysis modalities 94
L-carnitine in uremic anemia 94
Endoscopy as a tool for diagnosing and treating gastrointestinal angiodysplasia in haemodialysis patients 93
Toward personalized hemodialysis by low molecular weight amino-containing compounds: future perspective of patient metabolic fingerprint 93
Erythropoietin induces miRNA-210 by JAK2/STAT5 signaling in PBMCs of End-stage Renal Disease patients 93
Calcimimetic R-568 and its enantiomer induce a rapid, reversible, and only partially endothelium-mediated vasodilation in perfused mesenteric arteries from normotensive and spontaneously hypertensive rats 91
Glomerulopathies associated with psoriasis: a report of three cases 91
Leukocyte adhesion molecules and leukocyte-platelet interactions during hemodialysis: effects of different synthetic membranes 90
Vascular inflammation in end-stage renal disease: the red blood cell connection 90
Prevalence and associated variables of postdialysis fatigue: results of a prospective multicenter study 90
Enhanced adherence of human uremic erythrocytes to vascular endothelium: role of phosphatidylserine exposure 89
New treatment approaches for the anemia of CKD 89
Efficacy of sodium thiosulphate in a case of calciphylaxis in a chronic nephropathic ninety-year-old patient on conservative therapy 88
Management of IgA nephropathy 87
Biocompatibility assessment of haemodialysis membrane materials by proteomic investigations 87
Increased erythrocyte phosphatidylserine exposure in chronic renal failure 86
Platelet activation and platelet-erythrocyte aggregates in end-stage renal disease patients on hemodialysis 85
Proteomic analysis of protein adsorption onto haemodialysis membranes 85
Prevalence and severity of postdialysis fatigue are higher in patients on chronic hemodialysis with functional disability 81
Formalin-fixed paraffin-embedded renal biopsy tissues: an underexploited biospecimen resource for gene expression profiling in IgA nephropathy 80
Red blood cells may contribute to hypercoagulability in uraemia via enhanced surface exposure of phosphatidylserine 79
null 79
Approccio diagnostico al sanguinamento gastrointestinale occulto nel paizente in trattamento emodialitico 77
Hypercoagulability in uraemia: role of increased surface exposure of phosphatidylserine on erythrocytes 77
Interactions between platelets and leukocytes during hemodialysis 75
null 74
Surface Antigen Expression and Platelet Neutrophil Interactions in Haemodialysis 74
Studio microbiologico in vitro su di un nuovo connettore per dialisi peritoneale 74
Proteomics and nephrology 74
Pro-inflammatory effects of erythrocytes from uremic patients on cultured human endothelial cells: insights into the signaling pathways 74
Increased adhesion of uraemic red blood cells to vascular endothelium causes reduction of endothelial nitric oxide synthase expression 74
Rene e Gravidanza 74
Pro-atherogenic effect of uraemic red blood cell (RBC): role of RBC surface-exposed phosphatidylserine 73
Removal of uraemic plasma factor(s) using different dialysis modalities reduces phosphatidylserine exposure in red blood cells. 72
Do haemodialysis membranes influence atherosclerosis? A one-year prospective study 72
Nephrotoxicity Associated with Novel Anticancer Agents (Aflibercept, Dasatinib, Nivolumab): Case Series and Nephrological Considerations 72
Proteomic Characterization of a New asymmetric Cellulose Triacetate Membrane for Hemodialysis 72
L'angiodisplasia gastroenterica nel paziente uremico in trattamento emodialitico regolare. Due casi clinici 71
L’accesso vascolare negli anziani: prevenzione o spreco di risorse? 71
Leukapheresis and chronic inflammatory bowel disease: an additional obligation for the nephrologist 71
Malattie renali cistiche 71
Biocompatibility of Surface-Modified Membranes for Chronic Hemodialysis Therapy 70
Association of chronic microinflammation, progression of atherosclerosis and outcome in maintenance hemodialysis (HD): long term effect of dialytic membranes 69
Rene e paraproteine 69
Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal Dialysis 67
Serum fetuin-a in hemodialysis: a link between derangement of calcium-phosphorus homeostasis and progression of atherosclerosis? 67
Involvement of phosphatidylserine exposure in the recognition and phagocytosis of uremic erythrocytes 66
L-carnitine may decrease platelet activation response with phosphatidylserine exposure in chronic uraemia 66
Nefropatie glomerulari familiari ed ereditarie 66
Utilità di uno screening urinario in età scolastica 64
L’uremia batte…dove il dente duole!!! 62
Increased platelet phosphatidylserine exposure and caspase activation in chronic uremia 61
Prognosis of CKD patients receiving outpatient nephrology care in Italy 60
Efficacy of hemoperfusion with Seraph-100 in series with single pass albumin dialysis in acute hepatitis B infection: A case report 56
null 55
Intensity, Duration, and Frequency of Post‐Dialysis Fatigue in Patients on Chronic Haemodialysis 55
Treatment options for anemia in kidney transplant patients: a review 51
The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care 51
Post-dialysis fatigue and survival in patients on chronic hemodialysis 47
Coupling Osmotic Efficacy with Biocompatibility in Peritoneal Dialysis: A Stiff Challenge 46
Low serum fetuin-A levels are associated with an higher cardiovascular morbidity and mortality risk in hemodialysis patients 46
Chyloperitoneum in Peritoneal Dialysis Secondary to Calcium Channel Blocker Use: Case Series and Literature Review 44
null 42
null 41
Totale 9.053
Categoria #
all - tutte 38.546
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.546


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021730 0 4 97 26 87 126 8 43 79 123 75 62
2021/2022564 35 21 9 120 31 8 21 28 51 36 47 157
2022/20231.502 139 191 87 156 133 267 89 114 222 15 50 39
2023/2024812 59 20 58 32 41 280 167 30 4 20 19 82
2024/20251.762 114 246 203 90 46 71 43 84 264 74 223 304
2025/2026405 333 72 0 0 0 0 0 0 0 0 0 0
Totale 9.431